CRW vs. ONT, UPR, SPI, PRTC, GNS, AMS, MXCT, BMK, NIOX, and BVXP
Should you be buying Craneware stock or one of its competitors? The main competitors of Craneware include Oxford Nanopore Technologies (ONT), Uniphar (UPR), Spire Healthcare Group (SPI), PureTech Health (PRTC), Genus (GNS), Advanced Medical Solutions Group (AMS), MaxCyte (MXCT), Benchmark (BMK), NIOX Group (NIOX), and Bioventix (BVXP). These companies are all part of the "medical" sector.
Oxford Nanopore Technologies (LON:ONT) and Craneware (LON:CRW) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, community ranking, analyst recommendations and valuation.
Oxford Nanopore Technologies has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500. Comparatively, Craneware has a beta of 0.14, suggesting that its share price is 86% less volatile than the S&P 500.
Craneware has a net margin of 5.19% compared to Craneware's net margin of -91.06%. Oxford Nanopore Technologies' return on equity of 2.86% beat Craneware's return on equity.
Craneware has higher revenue and earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.
38.4% of Oxford Nanopore Technologies shares are owned by institutional investors. Comparatively, 58.8% of Craneware shares are owned by institutional investors. 30.1% of Oxford Nanopore Technologies shares are owned by company insiders. Comparatively, 20.8% of Craneware shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Oxford Nanopore Technologies presently has a consensus price target of GBX 303.75, suggesting a potential upside of 213.47%. Craneware has a consensus price target of GBX 2,600, suggesting a potential upside of 20.37%. Given Craneware's higher probable upside, equities analysts clearly believe Oxford Nanopore Technologies is more favorable than Craneware.
Craneware received 208 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 71.43% of users gave Craneware an outperform vote.
In the previous week, Craneware had 2 more articles in the media than Oxford Nanopore Technologies. MarketBeat recorded 3 mentions for Craneware and 1 mentions for Oxford Nanopore Technologies. Oxford Nanopore Technologies' average media sentiment score of 0.60 beat Craneware's score of -0.92 indicating that Craneware is being referred to more favorably in the news media.
Summary
Craneware beats Oxford Nanopore Technologies on 11 of the 17 factors compared between the two stocks.
Get Craneware News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CRW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Craneware Competitors List
Related Companies and Tools
